Four normal (ages, 1 to 6 years) and 12 Abyssinian cats at four
different clinical stages of ARCD were studied. Five cats were at stage
1 (ages, 1 to 2.5 years), 3 at stage 2 (ages, 2 to 3 years), 2 at stage
3 (ages, 2 to 3 years), and 2 at stage 4 (ages, 4 to 6 years). The cats
were anesthetized using a single intramuscular dose of medetomidine
hydrochloride (0.25 mg Domitor vet.; Orion Pharma AB, Animal
Health, Sollentina, Sweden). After 15 minutes an injection of
ketamine (15 mg Ketalar; Parke–Davis, a division of Warner Lambert
Nordic AB, Solna, Sweden) was similarly given. Ketamine was iterated
after 30 minutes of anesthesia using half the initial dose. Eyes were
dilated using tropicamide (Mydriacyl; Alcon, Alcon Nordiska AB,
Stockholm, Sweden). The research was performed in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research.